Veradermics, Incorporated
Market Cap
4.6B
Short interest (Jul 15)
9.4%
Net Short (Jul 27 ): 0.2%
Borrow Fee
1.25%
↓ 2.3%
Available Shares
300K
↓ 65.5%
Price Chart
Company Overview
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.